|
Volumn 38, Issue 5, 1986, Pages 374-379
|
Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in‐vivo α1‐, α2‐ and 5‐HT2‐receptor antagonism and in‐vitro affinity for α1‐, α2‐ and 5‐HT2‐receptors: comparison with ketanserin
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR;
BUTANSERIN;
FLUFYLLINE;
FLUPROFYLLINE;
KETANSERIN;
MIANSERIN;
MIANSERIN H 3;
PRAZOSIN;
PRAZOSIN H 3;
RADIOISOTOPE;
RITANSERIN;
SEGANSERIN;
SEROTONIN 2 RECEPTOR;
SGD 144/80;
SGD 195/78;
UNCLASSIFIED DRUG;
YOHIMBINE;
YOHIMBINE H 3;
ANIMAL EXPERIMENT;
ARTICLE;
CENTRAL NERVOUS SYSTEM;
DRUG COMPARISON;
DRUG INTERACTION;
DRUG RECEPTOR BINDING;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
PHARMACOKINETICS;
PRIORITY JOURNAL;
RAT;
ADRENERGIC ALPHA-ANTAGONISTS;
ANIMALS;
BINDING, COMPETITIVE;
BLOOD PRESSURE;
BRAIN;
DECEREBRATE STATE;
HISTAMINE H2 ANTAGONISTS;
KETANSERIN;
MALE;
PIPERIDINES;
RATS;
RATS, INBRED STRAINS;
RITANSERIN;
SEROTONIN ANTAGONISTS;
THEOPHYLLINE;
VASOCONSTRICTION;
|
EID: 0022576736
PISSN: 00223573
EISSN: 20427158
Source Type: Journal
DOI: 10.1111/j.2042-7158.1986.tb04590.x Document Type: Article |
Times cited : (19)
|
References (30)
|